Stomach Neoplasms: all 2,914 studies
Page 20 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction CarcinomaCompletedNCT03469557Phase 2
- Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric CancersStatus unknownNCT03468712Not applicable
- A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3Status unknownNCT03457844Phase 2
- Comparison of Ability of pCLE and WLE for Diagnosis and Cancer Tissue Acquisition in Advanced Gastric Cancer After Chemotherapy StatusStatus unknownNCT03449966Not applicable
- Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)Active, not recruitingNCT03448835Phase 2
- Comparison of Open Laparoscopic and Robotic Surgery in Gastric Cancer Resection.Status unknownNCT03447106Not applicable
- Comparison of Analgesic Effects According to Patient-controlled Epidural Analgesia Modes in Patients Undergoing Open GastrectomyStatus unknownNCT03430440Not applicable
- OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric CarcinomaCompletedNCT03429816Not applicable
- A Study of HIPEC Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer CellsStatus unknownNCT03428425Phase 2
- Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric CancerStatus unknownNCT03427684Phase 1/2
- Safety and Tolerability Evaluation Study of BVAC-B in Patients With HER2/Neu(Human Epithelial Growth Factor Receptor 2) Positive Gastric Cancer After Failure to Standard CareCompletedNCT03425773Phase 1
- Molecular Evaluation of Neoadjuvant Chemotherapy for Locally Advanced Gastric CancerCompletedNCT03425058
- Efficacy and Safety of a Preoperative Aerobic Exercise Program in Patients With Gastrointestinal Cancer.Status unknownNCT03423056Not applicable
- Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune ResponsivenessActive, not recruitingNCT03421288Phase 2
- Systematic Review and Meta-analysis of Cereal or Grain Consumption and Gastric CancerCompletedNCT03419663
- Intestinal Microbiome After GastrectomyCompletedNCT03418428
- Prehabilitation in Patients With Esophageal or Gastric CancersCompletedNCT03418298Not applicable
- Real World Evidence for the Cycle of Neoadjuvant Chemotherapy in Gastric Cancer With Shared Decision MakingStatus unknownNCT03413514Not applicable
- Dendritic Cell-based Immunotherapy in Treatment Gastric CancerStatus unknownNCT03410732Phase 2
- Ipilimumab or FOLFOX in Combination With Nivolumab and Trastuzumab in HER2 Positive EsophagoGastric AdenocarcinomaCompletedNCT03409848Phase 2
- A Validation Study of Relationships Among Genomic Gene Expression Profile, Prognosis and Prediction of Adjuvant Chemotherapy Benefit With Capecitabine and Oxaliplatin in Gastric Cancer Stage II and III (6th AJCC) Patients After D2 Surgery (CLASSIC)CompletedNCT03403296
- Study of Nimotuzumab and Irinotecan as Second Line With Recurrent or Metastatic Gastric AdenocarcinomaStatus unknownNCT03400592Phase 2
- XELOX for 4 Months Versus 6 Months in Gastric Cancer (LOMAC)CompletedNCT03399110Phase 3
- Study Title: Peri-operative Immuno-Chemotherapy in Operable Oesophageal and Gastric CancerActive, not recruitingNCT03399071Phase 2
- Prospective Comparison of Surgical Outcomes With Using Integrated Robotic Technology Versus Conventional Laparoscopy for Gastric Cancer SurgeryStatus unknownNCT03396354Not applicable
- Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal AdenocarcinomaCompletedNCT03395847Early Phase 1
- A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild TumorStatus unknownNCT03393416Phase 1
- Comparison of the Effect of Intravenous and Perineural Dexmedetomidine in Gastric Cancer SurgeryStatus unknownNCT03393403Not applicable
- Comparing the Quality of Life Between LADG and TLDG for Gastric Cancer_KLASS07 (CKLASS01)).CompletedNCT03393182Not applicable
- Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical ResectionStatus unknownNCT03392103Phase 2
- Incidence of Pancreatic Fistula After Radical GastrectomyStatus unknownNCT03391687
- The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.CompletedNCT03384511Phase 4
- OLGA and OLGIM Stage System for Gastric CancerCompletedNCT03380052
- TAS102 in Combination With NAL-IRI in Advanced GI CancersActive, not recruitingNCT03368963Phase 1/2
- Conversion Surgery in Stage IV or Unresectable Gastric CancerWithdrawnNCT03366961Not applicable
- HIPEC and Systemic Chemotherapy Combined With Apatinib in Unresectable Peritoneal Metastases From Gastric CancerTerminatedNCT03349827Not applicable
- Uncut Roux-en-Y vs Roux-en-YStatus unknownNCT03349398Not applicable
- Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination.Active, not recruitingNCT03348150Phase 3
- Muscle Dysfunction in Gastrointestinal or Hepatobiliary CancerActive, not recruitingNCT03347162
- Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer PatientsTerminatedNCT03342417Phase 2
- Research On the Optimized Treatment Method For Apatinib's Cure Of Advanced Gastric CancerStatus unknownNCT03334591Phase 2
- The Real World Study of Apatinib for Gastric Cancer Treatment in Anhui ProvinceStatus unknownNCT03333967
- PRS-343 in HER2-Positive Solid TumorsCompletedNCT03330561Phase 1
- Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine TumoursTerminatedNCT03328065
- Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant ChemotherapyStatus unknownNCT03322969Phase 2
- FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid TumorsCompletedNCT03319459Phase 1
- Peritoneal Lavage for Early Detecting Gene Mutation of Peritoneal Metastasis of Gastric CancerCompletedNCT03314649
- Clinical Outcomes of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric CancerCompletedNCT03313700Not applicable
- Genomic Testing and Resulting Medical DecisionsCompletedNCT03301493
- Perioperative Electroacupuncture for Gastric Cancer Patients After GastrectomyStatus unknownNCT03291574Not applicable
- Clinical Outcomes of Laparoscopic D1 Versus D2 Lymphadenectomy for Elderly Patients With Advanced Gastric CancerStatus unknownNCT03290209Phase 2
- Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric CancerStatus unknownNCT03286244Phase 1
- Incidence of Duodenal Stump Fistula After Gastrectomy for Gastric Cancer. A Randomized Controlled TrialStatus unknownNCT03277144Not applicable
- Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric CancerStatus unknownNCT03276156Phase 1
- Robotic Versus Laparoscopic Distal Gastrectomy With D2 Lymphadenectomy for Locally Advanced Gastric CancerStatus unknownNCT03273920Not applicable
- ERAS for Patients Received Neoadjuvant ChemotherapyCompletedNCT03272984Not applicable
- A Study of Apatinib Combined With S1 in Patients With Advanced Gastric CancerStatus unknownNCT03271073Phase 2
- Lymph Node 14v Dissection in Clinical Stage T3N+, T4N+ of Gastric CancerStatus unknownNCT03264807Phase 3
- Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric CancerStatus unknownNCT03263741Phase 2
- A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric CancerStatus unknownNCT03258034Phase 2
- Trial on Impact on the Hospital Stay, of an Early Oral Nutrition Protocol Applied to Patients After Total Gastrectomy. (DOPGT_2015)Status unknownNCT03257280Not applicable
- Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric CancerActive, not recruitingNCT03257163Phase 2
- Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric CancerStatus unknownNCT03255811Not applicable
- A Dose-escalation, Expansion Study of ARX788, in Advanced Solid Tumors Subjects With HER2 Expression (ACE-Pan Tumor 01)CompletedNCT03255070Phase 1
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Gastric CancerCompletedNCT03253939
- A Study of SC-007 in Subjects With Advanced CancerTerminatedNCT03253185Phase 1
- Robotic Resection for Patients With Gastric Gastrointestinal Stromal Tumors: a Single-center StudyCompletedNCT03238820Not applicable
- Neoadjuvant Chemotherapy for Patients With Advanced Gastric Cancer in ERAS Programs for Radical GastrectomyCompletedNCT03238404Not applicable
- Nonintervention Study on Peritoneal Metastasis of Stage IV Gastric CancerStatus unknownNCT03237507
- Multimodal Analgesia in Laparoscopic Radical Gastrectomy With Gastric Cancer: a Multi-center StudyStatus unknownNCT03236051Not applicable
- Apatinib Plus XELOX as Neoadjuvant Therapy in Locally Advanced Gastric CancerStatus unknownNCT03229096Phase 2
- QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsActive, not recruitingNCT03228667Phase 2
- Preoperative Stomach Cancer Induction Chemotherapy and Radiation TherapyStatus unknownNCT03223740Phase 3
- Pilot Study of Non-exposure Simple Suturing EFTR With Sentinel Lymph Node Navigation for EGC (Senorita3-pilot)Status unknownNCT03216174Not applicable
- Telomeric Abnormalities in Colorectal Diseases by Fluorescent in Situ Hybridization TechniqueStatus unknownNCT03208777
- Evaluation of PET and Laparoscopy in STagIng Advanced Gastric CancerActive, not recruitingNCT03208621
- Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric CancerStatus unknownNCT03192735Phase 2
- Gastric Cancer Precursor Lesions (GCPL) StudyCompletedNCT03188406
- Efficacy of HIPEC Combined With Systemic Chemotherapy and CRS on Peritoneal Metastases From Gastric CancerStatus unknownNCT03179579Phase 3
- Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT03170960Phase 1
- Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric CancerCompletedNCT03170180Phase 2
- The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive GastrectomyStatus unknownNCT03160924Phase 3
- To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid TumorsCompletedNCT03159585Phase 1
- Chilean Gastric Cancer Task Force (FORCE 1)CompletedNCT03158571
- Application Value of CTCs Detection for Advanced Gastric Cancer PatientsStatus unknownNCT03156777
- The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric CancerStatus unknownNCT03154983Phase 2
- Dose Escalation Study of Lithium With Oxaliplatin and Capecitabine in Advanced Oesophago-Gastric or Colorectal CancerTerminatedNCT03153280Phase 1
- Cytoreductive Surgery and Intraperitoneal Chemotherapy for Stomach CAncer: a Feasibility StudyTerminatedNCT03150628Phase 2
- Apatinib Combined With Paclitaxol as Second Line Therapy for Advanced Gastric Cancer.Status unknownNCT03144843Phase 2
- A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous ThromboembolismStatus unknownNCT03139487Phase 2
- Docetaxel and S-1 Combination Therapy as Second-line Treatment for Advanced Gastric CancerStatus unknownNCT03137004Phase 2
- Prospective Randomized Trial Comparing Endoscopic Submucosal Dissection Against Laparoscopic Assisted Gastrectomy for Treatment of Early Gastric CancerCompletedNCT03136354Not applicable
- Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)CompletedNCT03133286
- Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)CompletedNCT03130790Phase 2/3
- Immunomodulating Nutrients in Perioperative Patients With Gastric CancerCompletedNCT03123432Not applicable
- Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic ResectionCompletedNCT03123042Not applicable
- Home Parenteral Nutrition for Malnourished Unresectable Stage IV Gastric CancerCompletedNCT03121807Not applicable
- Enhanced Recovery After Surgery Program for Gastric Cancer: a Multi-center StudyStatus unknownNCT03121729Not applicable
- The Addition of Dexmedetomidine on Postoperative Sleep for Middle-aged and Elderly Patients With Gastric CancerStatus unknownNCT03117023Phase 3
- Apatinib for the Elderly Advanced Gastric CancerCompletedNCT03104283Phase 2